Genvec Inc (GNVC)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

65 W WATKINS MILL RD GAITHERSBURG, MD 20878

Develops and commercializes novel therapies that produce medically beneficial proteins at the site of disease. The company applies its gene based technologies to create product candidates, such as TNFerade for the treatment of cancer, and BIOBYPASS, to treat severe coronary artery disease.

View SEC Filings from GNVC instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding GNVC (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding GNVC BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SWIRSKY DOUGLAS J PRESIDENT AND CEO

  • Officer
  • Director
No longer subject to file 2017-06-16 0

BROUGH DOUGLAS E CHIEF SCIENTIFIC OFFICER

  • Officer
No longer subject to file 2017-06-16 0

BUTMAN BRYAN T SENIOR VICE PRESIDENT

  • Officer
No longer subject to file 2017-06-16 0

SCHNEEBAUM MARC R

  • Director
No longer subject to file 2017-06-16 0

KELLEY WILLAM N

  • Director
No longer subject to file 2017-06-16 0

HOCKMEYER WAYNE T

  • Director
No longer subject to file 2017-06-16 0

LOREN STEFAN

  • Director
No longer subject to file 2017-06-16 0

MALLETTE QUINTEROL J

  • Director
No longer subject to file 2017-06-16 0

LAMBERT JAMES VINCENT VP, ACCOUNTING & FINANCE

  • Officer
No longer subject to file 2017-06-16 0

RICHMAN MICHAEL

  • Director
No longer subject to file 2017-06-16 0

MMCAP INTERNATIONAL INC. SPC

  • 10% Owner
257,272 2017-03-03 0

ECOR1 CAPITAL, LLC

ECOR1 CAPITAL FUND, L.P.

ECOR1 CAPITAL FUND QUALIFIED, L.P.

NODELMAN OLEG

  • 10% Owner
  • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
5,936,559 2014-05-22 0

ECOR1 CAPITAL FUND QUALIFIED, L.P.

  • SEE EXPLANATION OF RESPONSES
736,457 2014-03-26 0

ECOR1 CAPITAL, LLC

ECOR1 CAPITAL FUND, L.P.

NODELMAN OLEG

  • 10% Owner
1,840,000 2013-11-25 0

HOROVITZ ZOLA P

  • Director
80,757 2013-09-03 0

COLLINS CYNTHIA PRESIDENT & CEO

  • Officer
  • Director
0 2013-01-23 0

MAHMOUD ADEL

  • Director
0 2012-07-11 0

CONNOR EDWARD M

  • Director
0 2012-07-11 0

ROONEY KEVIN M

  • Director
0 2012-07-11 0

FISCHER PAUL H PRESIDENT & CEO

  • Officer
  • Director
0 2012-01-18 0

TUCKER MICHAEL C VP, LEGAL AFFAIRS AND STRATEGY

  • Officer
0 2012-01-18 0

RUCH JOSHUA

  • Director
0 2010-06-16 0

THORNTON MARK OWENS SENIOR VICE PRESIDENT

  • Officer
0 2010-01-20 0

KING CHARLES RICHTER SENIOR VICE PRESIDENT

  • Officer
0 2009-01-22 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments